Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Greg Tourangeau Insider Profile
4 Followers
Greg Tourangeau, CAO at Fulcrum Therapeutics, holds 11.57K shares in Fulcrum Therapeutics (Ticker: FULC). Most recently, Greg Tourangeau Sold $236 shares of Fulcrum Therapeutics on May 09, 2024 for an estimated value of 1.83K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-46.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Greg Tourangeau's holdings
Insider Roles
CAO
Roles that Greg Tourangeau holds in companies
Most Profitable Insider Trade
The most profitable trade made by Greg Tourangeau
Greg Tourangeau's Trading History
List of latest transactions for each holding click on a transaction to see Greg Tourangeau's performance on stock
You May Also Like
Greg Tourangeau insider profile FAQ
What is the percentage of profitable transactions made by Greg Tourangeau?
The percentage of profitable transactions made by Greg Tourangeau is 50%.
What is the average return per transaction made by Greg Tourangeau?
The average return per transaction made by Greg Tourangeau is -46.40%.
What stocks does Greg Tourangeau hold?
Greg Tourangeau holds: FULC stocks.
What was Greg Tourangeau’s latest transaction?
Greg Tourangeau latest transaction was an Informative Sell of $1.83K.
What was Greg Tourangeau's most profitable transaction?
Greg Tourangeau’s most profitable transaction was an Informative Sell of FULC stock on May 9, 2024. The return on the trade was 42.00%.
What is Greg Tourangeau's role in Fulcrum Therapeutics?
Greg Tourangeau's role in Fulcrum Therapeutics is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.